Bristol Myers Squibbs anticoagulant Eliquis (Apixaban) remains widely used, but Q1 sales declined to $3.57 billion (-4%)
Patients should view potential benefits beyond approved indications cautiously and discuss the available evidence, limitations and risks with a licensed medical provider
On April 30, 2026, the FDA published a proposed rule in the Federal Register (docket 2026-08552, 91 Fed
Total provider network size and state-by-state licensure details are not specified on the website
Diagnostic features include symmetrical presentation, negative Stemmer's sign (ability to pinch skin at the base of the toes), and absence of pitting edema
GLP-1 plays a role in reducing appetite, slowing gastric emptying, and improving insulin secretion